Joel Latham Archives | Cannabiz

Company news: Medicinal Harvest; Cannasouth/Eqalis; Cann Group; MGC Pharma; Incannex; Neurotech

by Martin Lane May 3, 2023April 30, 2024

Contract cultivator Medicinal Harvest is building additional indoor cultivation space at its South-East Queensland facility that […]

Company news: Helius Therapeutics; Little Green Pharma; MGC Pharma; Incannex

by Martin Lane and Steve Jones December 7, 2022April 29, 2024

Incannex secures A$13m placement but share price dives

by Steve Jones December 5, 2022April 29, 2024

Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria

by Martin Lane October 20, 2022April 29, 2024

Company news: MediCann Health; Creso Pharma; Botanix Pharmaceuticals; Incannex

by Martin Lane September 7, 2022April 29, 2024

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

by Martin Lane July 22, 2022April 29, 2024

Dr Sud Argawal steps down from Incannex board

by Martin Lane June 28, 2022April 29, 2024

Incannex progresses APIRx acquisition

by Martin Lane May 13, 2022April 29, 2024

Company news: Medigrowth; Greenfern Industries; Incannex; Cannatrek; MediPharm Labs; Cresco Labs

by Martin Lane March 24, 2022April 29, 2024

Company news: Emyria; Incannex; Epsilon; AusCann

by Martin Lane March 8, 2022April 29, 2024